Climb Bio, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 3 →Insiders7 insiders bought $779,626 in 3 open-market buys. 1 insider sold $878,963, all 4 sales on a 10b5-1 plan.→HoldersRa 19.7%FMR 11.8%UBS 5.9%→Financing →PeersClosest companies: VRDN, CGEM, APGE→
From the filings
Figures
- Net income
- −$57.6Mlast 12 months
- Operating cash flow
- −$53.3Mlast 12 months
- Cash and equivalents
- $44.1Mat the last balance sheet
- Shares outstanding
- 57.4M shareson issue